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Abstract 
This study examines the concerns and beliefs about medication reported by 
patients with non-malignant chronic pain encountered within general practice. 
Two hundred and thirty-nine patients with chronic pain took part in this 
research. Patients completed the Pain Medication Attitudes Questionnaire 
(PMAQ), a measure of patient concerns and beliefs relating to addiction, 
withdrawal, side-effects, mistrust in doctors,  perceived need of medication, 
scrutiny from others, and tolerance. The data revealed that patient concerns 
and beliefs predicted general medication non-adherence. In addition, 
concerns were related to the direction of non-adherence: overuse of 
medication was related to increased perceived need for medication and 
greater concern over side effects; underuse was related to decreased 
concerns over withdrawal and increased mistrust in the prescribing doctor. 
Analyses also indicated that patient attitudes and concerns about medication 
were more predictive of non-adherence than both level of pain and the 
reported frequency of experienced side effects. This research contributes to 
the increasing evidence that patient attitudes and beliefs about pain 
medication are associated with adherence behavior. Training general 
practitioners to identify and address these concerns may reduce concerns, 







Chronic non-malignant pain presents physicians with challenges, 
including symptoms that often defy clear etiology and diagnosis. Appropriate 
treatment may include a complex combination of rehabilitative, psychological 
and behavioral methods. Medication remains, however, the most common 
component of treatment. Despite a consensus on the value of analgesic 
prescription in primary care [10,13], ineffective treatment, including 
undertreatment [3,6], remains a significant problem.   
 Patient adherence to prescribed medication may present additional 
complications. Medication adherence is necessary for the accurate 
assessment of treatment effectiveness and for the overall management of a 
patient‟s package of care. Both over and underuse of analgesic medication 
can reduce the effectiveness of pain management. Non-adherence to 
prescribed medication by chronic pain patients is common [2,4] and may have 
many different causes [2].  
Both physicians and patients report concerns about the impact of 
medication [10,12]. The patient‟s concerns, however, may provide the key to 
more effective medication use for chronic pain. A study in secondary and 
tertiary care by McCracken, Hoskins and Eccleston [8] illustrated that patients‟ 
concerns about medication predicted both the extent and direction of non-
adherence, whether that be over or underuse. Understanding and addressing 
the concerns of the patient may increase adherence, which in turn may 
reduce physician‟s own concerns about the impact of medication on patients.  
In contrast to specialty care, primary care encompasses a broader 
range of patients with diverse treatment histories. Despite primary care 
typically being the initial and most frequent point of contact for chronic pain 
patients the primary care experience remains under-researched [16]. The 
concerns of patients seen in primary care cannot be assumed to be equivalent 
to those in specialist care because their levels of distress and disability differ, 
their treatment histories differ, and the level of training in pain management of 
the administering physician is often very different. Compared with specialist 
physicians, General Practitioners may experience higher levels of medication 
concerns [11], which are associated with reports of insufficient training about 
chronic non-malignant pain [7,17]. Given the importance of the patient-
practitioner relationship the concerns of the GP may exacerbate those of the 
patient. Thus, investigation of the concerns of chronic non-malignant pain 
patients encountered in primary care appears essential to (a) inform and 
better equip primary care practitioners, (b) guide treatment to diminish the 
patient‟s concerns, (c) improve medication adherence, and (d) reduce 
physician concerns. 
The aim of this study was to extend previous research into the 
associations between the concerns of chronic non-malignant pain patients 
about medication and non-adherence. Whereas previous investigation has 
focused on the concerns of patients receiving specialist care [8], this study 
focuses on the broader range of patients encountered within general practice. 
As in earlier studies it was predicted that patients' concerns about medication 
for pain would correlate with their patterns of medication use. Underuse of 
medication, which is often omitted from research, as well as overuse, were 
both assessed as patterns of non-adherence [2].  
2. Method 
2.1. Participants 
Two hundred and thirty-nine patients with chronic pain took part in this 






Over a third (37.6%) of the participants were either working part time, 
retired or not working because of their pain; 41.8% of the participants received 
benefits, of which the most common were Income Support and Disabled 
Living Allowance. The sample of participants in this study was identical to the 
sample in a previously published study [9] although the variables of primary 
interest are completely separate. 
2.2. Procedure 
This study was approved by the local ethics committee. Chronic non-
malignant pain patients were contacted through 20 GPs from 10 primary care 
practices throughout South West England. A computer records search by 
each practice was conducted to find chronic pain patients. Each GP wrote to 
between 20-40 chronic pain patients (CPPs) asking for their permission to be 
contacted directly by the research team from the Centre for Pain Research 
(N=664). Three hundred and twenty-three (48.6%) of the CPPs agreed to be 
contacted directly. Using standard mail survey methods questionnaires were 
sent to these 323 CPPs. One follow-up reminder was sent to non-responders. 
Completed questionnaires and written consent forms were received from 239. 
Therefore, the overall response rate was 36% of those originally contacted by 
their GP, perhaps due to the employment of a very conservative recruitment 
strategy.  
2.3. Measures 
2.3.1 Pain Medication Attitudes Questionnaire [8] 
Concerns and beliefs about pain medication were assessed using the 
PMAQ, a 47-item questionnaire including seven subscales: Concerns about 
addiction, concerns about withdrawal, concerns over side effects, mistrust in 
doctors, perceived need of medication, concerns over scrutiny from others, 
and worries about tolerance. Items are rated on a 6-point numerical scale 
(0=never true to 5=always true); nine items are reversed scored; and the 
subscales are mean scores of relevant items. Internal consistency reliability 
for these subscales is adequate based on Cronbach‟s alpha values ranging 
from .77 to .85 [8].  Validity was demonstrated in the previous study through 
significant predicted relations between the subscales and measures of 
medication use, disability, and emotional distress. 
Patient demographic information and pain and treatment history were 
collected. Participants‟ pain intensity was assessed by an 11-point numerical 
rating scale using the anchors „no pain‟ and „worst pain possible‟. Medication 
information (both prescription and non-prescription medication), dosage, and 
frequency of use were also collected.  
Medication adherence was assessed by replicating the method 
employed by McCracken and colleagues [8]. Similar to previous self-report 
approaches to adherence assessment, a series of brief questions were 
employed to assess general use rather than use of specific medication, to 
allow comparison across participants who typically have varying medication 
combinations [5]. First, underuse of medication was assessed by participant 
response to two questions about the frequency with which they take less 
medication than prescribed and miss doses respectively. Similarly, 
participants were asked two questions relating to frequency of taking more 
medication than prescribed and taking extra doses to assess overuse of 
medication. Participants responded to these medication use questions on a 5-
point scale (0=never, 4=always); underuse and overuse scores were the 
mean values across the two respectively question pairs. Second, general non-
adherence was the accumulative score across all four questions.  Therefore, 
each participant received three continuous variable ratings of non-adherence: 
general, underuse and overuse. The item pairs demonstrated adequate to 
good internal consistency for underuse (α = .61) and overuse (α = .86) 
respectively. There was no correlation between items of under and over use 
(all ps > .69). 
Finally, participants reported the frequency of ten common adverse 
effects of analgesics (i.e., drowsiness, impaired concentration, nausea, 
constipation, rash, dry eyes, agitation, dizziness, confusion, and headache). 
For ease of comprehension these were described using the more common 
term “side effects”. In what follows we report this more common term to reflect 
the question asked. 
3. Results 
3.1 Patient Report of Pain 
Patients reported a median pain duration of 10 years (range 0.33 – 50 
years). Ninety-four percent of the participants judged their pain to be a long 
term problem and 64.0% of the participants experienced their pain constantly. 
The mean present pain intensity rating was 5.2 (SD=2.5); and the mean „usual 
intensity over the last week‟ was 6.1 (SD=2.3). Most participants (99.2%) gave 
at least one reason for their pain, the most common one was osteoarthritis 
(53.1%). Approximately half did not know a cause for pain (49.4%); of those 
who did, just under a quarter (24.0%) cited accident. Thirty-seven percent of 
the participants had undergone an operation relating to their pain; of those, 
38.2% had undergone one surgical operation, 26.9% had two, and 35.0% had 
three or more. 
3.2. Patterns of Analgesic Use 
Participants reported being prescribed between one and 21 different 
medications; with a modal response of two (mean=4.3, SD=3.0). The most 
commonly reported medication types were weak opioids (67.4%), followed by 
prescribed NSAIDs (50.6%), over-the-counter (OTC) medications (primarily 
including paracetamol; 36.8%), tricyclic antidepressants (19.2%), 
anticonvulsants (8.8%), and strong opioids (8.4%). The separation of weak 
and strong opioids was employed as this is a common classification of these 
types of medications; it should be acknowledged, however, that medication 
strength is also contingent on dosage [1]. 
Patient responses regarding adherence were examined initially to 
understand the extent of deviation from prescription instruction. Although 
75.6% of participants indicated that they took medication exactly as their 
physician instructed in response to the direct yes or no question “do you take 
your medication exactly as prescribed?”, when further questioned almost half 
the participants indicated that they either take less medication (47.6%) and/or 
miss prescribed doses at least some of the time (52.0%). Approximately a 
quarter of the participants also stated that they either take more, or take an 
extra dose of medication at least some of the time, 23.5% and 30.4%, 
respectively. The average rate of reported non-adherence across four 
questions relating to medication use was 38.4%; 18.8% reported instances of 
both under and over use. 
When asked to specify a reason for either taking less, or missing a 
dose of medication, just under a third of patients cited “low level of pain,” 
31.8%, 18.4% cited “forgetting”, and 13.4% cited “concern about side effects” 
as the reason. Only very small numbers of participants cited “worries about 
the medication losing its effectiveness” (7.5%), “addiction or dependence” 
(7.1%), “what people may think” (0.4%) or “cost of medication” (0.8%) as 
reasons for taking less medication than prescribed.  
When analyzing the responses of those patients who stated that they 
sometimes take more, or take an extra dose of medication, most participants 
endorsed the reason “too much pain to tolerate” (33.9%); a small percentage 
cited the reasons “to help cope with a particular task” (7.5%), “have to do 
something and have no alternative” (2.1%), “feeling emotionally upset” (1.3%),  
“feeling unsure” (0.8%), or having “an urge to take it” (0.4%).  
3.3. PMAQ Item and Patterns of Use Analyses  
Correlation analyses were conducted to explore the relations between 
patient concerns, level and direction of non-adherence, and frequency of side 





 Higher levels of general non-adherence were associated with 
increased concerns about medication side effects and developing tolerance 
and addiction, as well as a greater mistrust in the prescribing doctor, and 
concern about scrutiny from others. Medication underuse was negatively 
associated with perceived need for medication and concerns over withdrawal, 
and positively associated with mistrust in the prescribing doctor. Both 
medication overuse and frequency of side effects experienced were positively 
related to all patient concerns examined.  
Examining the relations between frequency of side effects experienced 
and non-adherence (general, over and under use) demonstrated a 
significantly positive correlation with overuse only. Overuse of medication was 
associated with increased frequency of side effects. Due to overuse and 
frequency of side effects being related to both each other and all examined 
patient concerns, a series of partial correlations controlling for frequency of 
side effects were conducted to clarify the associations between overuse and 
concern (N = 184 in all cases, a reduction from the total sample size due to 
incomplete participant responses). These analyses reduced the number of 
significant positive correlations between overuse and patient concern to: 
concerns over side effects (r(181) = .18, p = .02) and developing tolerance 
(r(181) = .25, p = .001), as well as perceived need for medication (r(181) = 
.28, p < .001). Furthermore, the same partial correlation method was 
employed to examine the other medication adherence variables and concern 
over side effects. The results demonstrated that concern over side effects 
remained positively associated with general non-adherence (r(181) = .21, p = 
.005) and overuse (r(181) = .18, p = .02) even when accounting for actual 
occurrence of side effects.  
Comparison of concerns dependent on whether the patient reported 
some opioid use demonstrated increased concern about addiction compared 
to those who did not use opioids (t(230) = 3.07, p = .002). This comparison 
should be interpreted with caution, however, as it cannot account for the 
impact of the differing combinations of other medications taken by patients 
across these two groups. 
3.4. Regression Analyses of PMAQ Scores in Relation to Medication Use  
To examine combined and unique relations of the PMAQ scores with 
measures of medication adherence, we calculated a series of hierarchical 
multiple regression analyses. The criterion variables in these analyses were 
the three categories of medication adherence: general non-adherence, 
overuse, and underuse. In the first step of each equation level of pain was 
entered, in order to examine its ability to predict each of the outcome variables 
and to control variance attributable to pain. In the second step the scores for 
seven patient concerns and beliefs measured by PMAQ were entered, based 
on statistical criteria (p < .05 to enter, p > .10 to remove). Results of the three 








Level of pain accounted for a significant increment of variance in underuse but 
not overuse or general non-adherence. Lower levels of pain predicted more 
underuse. Other predictors of medication adherence differed dependent on 
direction of non-adherence. Underuse was positively predicted by mistrust of 
prescribing doctor and negatively predicted by concern about withdrawal. 
Overuse was positively predicted by perceived need for medication and 
concerns about side effects. The respective regression models explained 
19.1% of variance in general non-adherence, 19.6% of variance in underuse 
of medication, and 18.9% of variance in overuse of medication.  
An additional regression exploring general non-adherence was 
conducted substituting frequency of experienced side effects as a predictor in 
the place of the patient concern variables. The model was non-significant, F(2, 
183) = 2.11, p = .12, R2 = .02.  
4. Discussion 
The primary purpose of this research was to examine concerns and 
beliefs about medication in patients with chronic pain treated in primary care, 
and to further examine their association with non-adherence to prescribed 
medication. Medication non-adherence has frequently been identified as an 
area of concern for prescribing General Practitioners, and it is presumed that 
patient concerns about medications may help explain and reduce non-
adherence. The study findings offer support to this hypothesis and further 
propose that specific concerns may be related to particular patterns of non-
adherence.  
Consistent with previous reports [2], non-adherence was common. 
Dependent on the wording of the question, 23.5-52% of patients reported 
some degree of non-adherence. Furthermore, the present study supports 
previous research suggesting that specific concerns about medication are 
predictive of both general non-adherence and direction of non-adherence [8].  
Overall, the regression results were relatively consistent with the 
correlation coefficients. General non-adherence was associated with greater 
levels of mistrust in the prescribing doctor, greater concerns about potential 
side effects of the medication, and lower levels of concern about withdrawal 
from medication. On further analysis, patient concerns that were predictive of 
general non-adherence had specific relations with either over or under use, 
but not both. Underuse was associated with lower levels of perceived pain, 
lower levels of concern about withdrawal, and greater levels of mistrust in the 
doctor. Overuse was also associated with greater levels of concern about side 
effects and greater perceived need for medication. Perceived need for 
medication was the only factor that was predictive of specific pattern of non-
adherence, namely overuse, but not general non-adherence. These results 
suggest two conclusions. First, general non-adherence to prescribed 
medication may be the result of patient concerns and attitudes towards their 
medication. Second, these concerns may not only influence whether the 
patient deviates from their prescribed course of medication, but also in what 
form this deviation manifests itself, in particular whether it results in an 
increase or decrease of consumption.  
Those overusing medication report greater concern about side effects 
of medication; however, they also report an increased perceived need for the 
medication. Many individuals may consider medication to be essential whilst 
also having significant concerns about the impact the medication will have 
upon them. It is possible that for some patients these conflicting attitudes may 
exacerbate concern and cause further distress.  
The results also suggest that the positive association between 
concerns over side effects and both non-adherence and overuse persist 
irrespective of the actual frequency of side effects experienced. In addition, 
level of pain experienced explained the smallest amount of variance in all 
patterns of medication use, and was not a significant predictor of overuse or 
general non-adherence. These findings demonstrate further evidence that 
patient attitudes and concerns about medication appear to play a more 
significant role in determining non-adherence than actual physical experience 
of both pain and medication.  
Of particular interest is the finding that greater mistrust in the 
prescribing doctor predicts underuse of medication. The patient-doctor 
relationship is an important component of treatment, one that is reliant on 
openness and trust [14]. In the present study 28.5% of patients reported 
concerns that their doctor was not adequately educating them on the nature of 
the medication being prescribed. This finding may indicate that some patient 
concerns are not being adequately addressed through interactions with the 
GP and the explanations provided; that medication concerns are not being 
reduced, and that trust may be compromised.  
These patient concerns may reflect those expressed by GPs 
themselves. Primary care practitioner concerns relating to insufficient training 
about chronic non-malignant pain and appropriate treatment appear common 
[7,17]. These concerns reportedly impact on GP prescription behaviors 
[10,15,18], thus they are likely to also influence the satisfaction of the patient-
doctor interaction for both parties. Appropriate training and professional 
development to better equip GPs with the knowledge and expertise to treat 
chronic pain is required. Such a training program may diminish the concerns 
of the prescribing doctor. Furthermore, by addressing the relations between 
patient concerns and non-adherence exhibited in this research, practitioners 
may also be able to increase patient adherence. Non-adherence is an 
important issue as it undermines the treatment plan, can mislead subsequent 
treatment progression and frequently results in unwanted outcomes. Targeting 
patient concern is, therefore, potentially a vital component to adherence 
promotion. 
The research findings are consistent with previous investigation within 
secondary and tertiary care [8], however, they also demonstrate some notable 
differences. First, within the broad range of patients encountered in general 
practice, receiving varying levels of treatment, the reported range of non-
adherence was lower than the 36-75% previously reported in specialized care. 
This may suggest a greater instance of medication over and/or under use 
when considering patients receiving secondary and tertiary care, excluding 
primary care. Second, although patient concerns consistently predicted 
adherence across the studies, there was variation in the type and combination 
of these concerns. Additionally, with the exception of overuse, the predictive 
concerns of this sample of patients explained a greater percentage of 
variance in medication adherence. The results may indicate that stage of 
treatment (i.e., primary, secondary, tertiary) is related to different 
combinations of patient concerns influencing medication adherence. Further 
research directly comparing patients at different stages of treatment is 
required to clarify these potential associations. 
The study has some limitations. First, although the study extends 
previous investigations, sampling from primary care settings, the actual extent 
and type of care received by the patient was not assessed. The research, 
consequently, may display the differences in concerns of the broader sample 
in comparison with the specialist sample; however, the potential differences in 
predictive concerns of those at different stages of treatment (e.g. primary care 
versus secondary) cannot be determined. Second, the study design was 
cross-sectional and so causal relations between the assessed variables 
cannot be determined. Third, we measured medication behavior by self-
report, so actual behavior was not sampled. Further research could also 
explore differences between concerns relating to immediate and long-term 
use; as well as adherence to different types of medication. Finally, the present 
methodology cannot account for changes in concern within the same patient 
that may lead to variation in medication non-adherence, changes that may 
lead to underuse in some circumstances and overuse in others. 
5. Conclusion 
 This research contributes to the increasing evidence suggesting that 
patient concerns and beliefs about medication are associated with adherence 
behavior. In addition, direction of non-adherence was related to specific types 
of concern. Patient concerns appear more pivotal in determining non-
adherence than both level of pain and frequency of side effects experienced. 
This study expands upon previous research in secondary and tertiary care 
settings and suggests that significant concerns are also present in the broad 
range of patients encountered in primary care. A necessary step towards 
diminishing the concerns of both patient and practitioner, as well as increasing 
medication adherence, may involve additional training in the treatment of 
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Table 1. Demographic Characteristics of Study Participants. 
                                                                                  %
*
 
Sex   
 Male 42.8 
 Female 58.2 
Age   
 Mean (SD) 61.46 (13.73) years 
 Range 25-94 years 
Marital status   
 Married 61.5 
 Widowed 16.3 
 Divorced 15.5 
 Single 6.3 
Ethnicity   
 White 95.8 
 Other 1.2 
 Undisclosed 3% 
Employment Full-time 13.4 
 Homemaker 4.6 
 Part-time  due to pain 1.7 
  not due to pain 8.8 
 Retired  due to pain 21.3 
  not due to pain 31.4 
 Not working due to pain 14.6 
  not due to pain 3.3 
* 
Actual percentage including non-responders 
 







Frequency of side effects 
experienced
 
Medication use      
 1. Non-adherence    .14 (184) 
 2. Underuse .75*** (216)   -.03 (187) 
 3. Overuse .68*** (216) .02 (216)  .22** (185) 
Concerns      
 Addiction .14*  (216) -.00 (220) .21** (219) .47*** (195) 
 Perceived need .02 (216) -.26*** (220) .32*** (219) .36*** (195) 
 Scrutiny .18** (216) .08 (220) .17* (219) .40*** (195) 
 Side effects .22** (216) .03 (220) .28*** (219) .58*** (195) 
 Tolerance .17* (216) -.07  (220) .32*** (219) .39*** (195) 
 Mistrust in doctor .31*** (216) .22** (220) .21** (219) .25*** (195) 
 Withdrawal -.08 (216) -.27*** (220) .02* (219) .44*** (195) 
NOTE: N values are reported in parentheses; N ranges from 184-220 due to incomplete participant responses. Underuse and Overuse were measured based 
on to participant response to questions relating to direction of deviation from prescribed dose (0 = never; 4 = always); Non-adherence was evaluated based 
on the composite score of underuse and overuse; Frequency of side effects experienced was determined by the sum frequency of 10 common adverse 
responses to medication (0 = never; 4 = always). 
 p < .05. 
 p < .01. 
 p < .001.  
  23 
23 
Table 3. Multiple Regression Analyses of Medication Concerns and 
Medication Use. 
Predictors sr
2 β R2 
Non-Adherence 
1. Level of pain .014 -.13  
2. Mistrust in doctor .036  .21**  
3. Side Effects .030  .24**  
4. Concern over withdrawal .052 -.34***  
   .19*** 
Underuse 
1. Level of Pain .015  -.14*  
2. Mistrust in doctor .030  .19**  
3. Concern over withdrawal .048 -.33**  
   .20*** 
Overuse 
1. Level of Pain .002 -.06  
2. Perceived need .050  .31***  
3. Side Effects .023  .21*  
   .19*** 
NOTE. A hierarchical method was used for entry of predictor variables. Dependent variables 
were Non-Adherence (n = 216), Underuse (n = 220), and Overuse (n = 219). Level of Pain 
(level of pain at time of completing questionnaire, rated 0 to 10) was forced into each equation 
in the first step. The subscales from the PMAQ were tested for entry after that based on 
statistical criteria (p to enter < .05, p to remove > .10). sr
2
 refers to the square of the semi-
partial correlation coefficient.  
  24 
24 
 p < .05. 
 p < .01. 
 p < .001.  
 
